DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

IOL Chemicals and Pharmaceuticals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 33 min ago·10 Sept 2026, 9:50 am

IOL Chem AND Pharma

IOL Chemicals and Pharmaceuticals Limited has informed exchanges that it is scheduled to hold an institutional investor meet or conference call. This announcement signals that the company is preparing to engage with analysts and large shareholders to discuss its business outlook and performance.

For investors, such meetings are significant as they provide a direct platform for the company to address market questions and share its strategic vision. It offers a chance to gauge management's confidence and clarity on future growth plans.

Investors should watch for updates on the company's guidance regarding its key product segments and operational efficiency. The discussion will likely focus on how the firm plans to navigate current market trends and capitalize on upcoming opportunities.